drugset / Trial / NCT03511066
A Study to Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A Infection
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a Phase IIb, Randomized, Double-blind, Multicenter, Placebo-controlled study evaluating the efficacy and safety of CT-P27 in subjects with acute uncomplicated influenza A infection.
Timeline
- Start
- 2016-12-09
- Primary completion
- 2018-03-09
- Completion
- 2018-06-15
Outcome
Outcome not reported
Stopped: “CT-P27 2.2 is inactivated”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CT-P27 | Unknown | 45 mg/kg | Intravenous |
| Subject | CT-P27 | Unknown | 90 mg/kg | Intravenous |